Colorectal liver metastases: Resect, ablate, or embolize

Research output: Contribution to journalReview articlepeer-review


The management of colorectal liver metastases (CRLM) is complex and should be individualized to each patient. Resectable CRLM benefit from surgical resection, preferably minimally invasive and parenchymal sparing, when feasible. Ablation is a viable alternative. Chemotherapy in this setting is potentially indicated in select patients, however, it has a clear role in unresectable CRLM. Newer locoregional therapies may benefit some unresectable CRLM with resistance to chemotherapy. Liver transplantation, a new therapy on the horizon for unresectable disease, has encouraging preliminary long-term survival outcomes for carefully selected patients.

Original languageEnglish
Article number100968
JournalSeminars in Colon and Rectal Surgery
Issue number3
StatePublished - Sep 2023


  • Ablation
  • Chemotherapy
  • Colorectal liver metastases
  • Embolization
  • Hepatectomy


Dive into the research topics of 'Colorectal liver metastases: Resect, ablate, or embolize'. Together they form a unique fingerprint.

Cite this